Tenofovir Disoproxil Fumarate Tablet
Product Images NDC 64380-714

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 64380-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

97ace9ef C343 42bb 8953 E6449244f265 01

97ace9ef C343 42bb 8953 E6449244f265 01
Chemical structure diagram of tenofovir disoproxil fumarate, the active ingredient in TENOFOVIR DISOPROXIL FUMARATE 300 mg tablets by Strides Pharma Science Limited.*
FDA Label Image

97ace9ef C343 42bb 8953 E6449244f265 02

97ace9ef C343 42bb 8953 E6449244f265 02
Label for Tenofovir Disoproxil Fumarate Tablets 300 mg by Strides Pharma Science Limited. The label specifies 30 film-coated tablets for oral use, with storage instructions and manufacturer details in Bengaluru, India. It includes the NDC 64380-714-04 and distributor information in East Brunswick, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.